Cefdinir
Active substance: cefdinir
CAPSULE · CEFDINIR 300 mg/1
United StatesActive
Marketing holder: Lupin Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CEFDINIR · 300 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-29c6-743f-8118-acaad53762c3,01a1208c-5c1e-7aa9-a4a9-d27834e655a3,01a1208c-6797-74c4-a6be-e86b4d043729,01a1208c-6a4e-7377-9e46-84ce8b74fd13,01a1208c-934a-7850-81d0-ec08b2b781d2;count=79 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68180-711
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 68180-711 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68180-711 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68180-711 · Verified 2026-10-09 · open in source